Cigar News: Largest Premium Cigar Manufacturers Challenge Improper FDA Regulation
Wednesday, July 17, 2019 — Washington, DC — The largest manufacturers in the premium cigar industry today filed a joint comment with the Food & Drug Administration (“FDA”) opposing the agency’s Proposed Substantial Equivalence (“SE”) Rule, which would require manufacturers to submit to an extensive application and testing regime to keep any “non-grandfathered” cigars on the market. Read more about Cigar News: Largest Premium Cigar Manufacturers Challenge Improper FDA Regulation[…]